Search research articles
Contact Us
Filters
Showing results (31-40 of 35) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 35 results.
JAMA Cardiology
|
April 20, 2022
SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents
Øystein Karlstad, Petteri Hovi, Anders Husby, et al.
Science Advances
|
September 3, 2025
HSF2 drives breast cancer progression by acting as a stage-specific switch between proliferation and invasion
Jenny C Pessa, Oona Paavolainen, Hendrik S E Hästbacka, et al.
Expert Review of Vaccines
|
November 13, 2024
Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study
Baltazar Nunes, James Humphreys, Nathalie Nicolay, et al.
BMJ (Clinical Research Ed.)
|
July 24, 2023
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses
Niklas Worm Andersson, Emilia Myrup Thiesson, Ulrike Baum, et al.
Influenza and Other Respiratory Viruses
|
November 28, 2025
Effectiveness of the 2023 Autumn XBB.1.5 COVID-19 Booster During Summer 2024 in the EU/EEA: A VEBIS Electronic Health Record Network Study
James Humphreys, Nathalie Nicolay, Toon Braeye, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 35) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 35 results.
JAMA Cardiology
|
April 20, 2022
SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents
Øystein Karlstad, Petteri Hovi, Anders Husby, et al.
Science Advances
|
September 3, 2025
HSF2 drives breast cancer progression by acting as a stage-specific switch between proliferation and invasion
Jenny C Pessa, Oona Paavolainen, Hendrik S E Hästbacka, et al.
Expert Review of Vaccines
|
November 13, 2024
Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study
Baltazar Nunes, James Humphreys, Nathalie Nicolay, et al.
BMJ (Clinical Research Ed.)
|
July 24, 2023
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses
Niklas Worm Andersson, Emilia Myrup Thiesson, Ulrike Baum, et al.
Influenza and Other Respiratory Viruses
|
November 28, 2025
Effectiveness of the 2023 Autumn XBB.1.5 COVID-19 Booster During Summer 2024 in the EU/EEA: A VEBIS Electronic Health Record Network Study
James Humphreys, Nathalie Nicolay, Toon Braeye, et al.
Page
of 4